Sonoma PharmaceuticalsSNOA
13F holders, Q1 2024 (March 31)16holders
1famous investor
$0.17avg. 13F price*
At the end of Q1 2024, 16 institutions reported holding Sonoma Pharmaceuticals Inc. (SNOA) in their 13F filings. The largest holders were Susquehanna International Group, LLP ($8K), Geode Capital Management, LLC ($6K) and State Street Corp. ($4K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Sonoma Pharmaceuticals Inc.
- CUSIP
- 83558L204
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $13K |
| Exits | 5 | $34K |
Ownership 16 holders
| Susquehanna International Group, LLP | 0.00% | New | 46,052 | $8K |
| Geode Capital Management, LLC | 0.00% | No change | 35,780 | $6K |
| State Street Corp. | 0.00% | No change | 24,315 | $4K |
| XTX Topco Ltd | 0.00% | New | 16,463 | $3K |
| Two Sigma Securities, LLC | 0.00% | New | 13,473 | $2K |
| Millennium Management | 0.00% | Reduce -59.2% | 13,016 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +25.9% | 11,980 | $2K |
| BlackRock Inc. | 0.00% | No change | 2,266 | $377 |
| US Bancorp \de | 0.00% | No change | 500 | $83 |
| Wells Fargo & Company | 0.00% | Add +16.2% | 122 | $20 |
| UBS Group AG | 0.00% | Reduce -98.8% | 103 | $17 |
| Morgan Stanley | 0.00% | No change | 86 | $14 |
| Allworth Financial LP | 0.00% | No change | 65 | $11 |
| Bank of America Corp. | 0.00% | No change | 44 | $7 |
| Cwm, LLC | 0.00% | New | 6 | $0 |
| HBC Financial Services, PLLC | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is SNOA's weight in each manager's 13F, not the share of Sonoma Pharmaceuticals Inc. the manager owns.